Skip to main contentSkip to navigation
Sirius Investors
Alpha Cognition Inc

Alpha Cognition Inc

ACOG
NASDAQHealthcare

Alpha Cognition Inc (ACOG) Investment Research Dashboard

About Alpha Cognition Inc (ACOG) stock analysis

Get live ACOG stock price $8.52, comprehensive Alpha Cognition Inc stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time ACOG stock data and investment insights.

8.52
4.70%Today
Market Cap
132.33M
Volume
92.37K
52W High
10.10
52W Low
4.50

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tab...

Company Information

CEO
Michael E. McFadden
Sector
Healthcare
Industry
Biotechnology
Employees
71

Contact Information

Address
1452 Hughes Street
Country
US

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Listed on major US exchange (NASDAQ) providing liquidity and transparency

Higher growth potential with elevated volatility (Beta: 2.33)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Alpha Cognition Inc shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Alpha Cognition Inc
  • Investors should consider how Alpha Cognition Inc fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

132.33M

P/E Ratio (TTM)

-5.26

Beta

2.33

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

72/100 ⭐⭐⭐⭐⭐

Overall
+0.4%
NYSE
+0.3%
NASDAQ
+0.5%
Sector1D1W1MP/EScore
Financial Services-0.3%+1.5%+4.5%19.6
93/100⭐⭐⭐⭐⭐
Healthcare+0.4%+0.2%+0.9%23.0
72/100⭐⭐⭐⭐⭐
Basic Materials+0.3%+2.1%-0.5%25.6
70/100⭐⭐⭐⭐⭐
Communication Services-2.4%-1.2%+2.1%21.3
67/100⭐⭐⭐⭐
Real Estate-0.0%+0.7%-2.2%27.9
53/100⭐⭐⭐
Consumer Defensive-0.8%-1.7%-0.4%29.3
48/100⭐⭐⭐
Consumer Cyclical-0.5%+1.0%-2.3%44.5
43/100⭐⭐⭐
Energy-2.7%-3.4%-5.3%18.3
32/100⭐⭐
Industrials-0.9%+1.4%-6.7%33.2
30/100⭐⭐
Technology-0.9%+0.1%-5.1%44.5
27/100⭐⭐
Utilities-1.1%-3.7%-8.7%24.2
14/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-08-06.